Skip to content

Clinical trials

Phase 3 Leukemia trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia Phase: Phase 3 Country / region: Taiwan Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20121
20143
20151
20161
20172
20191
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting3
Terminated2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Daiichi Sankyo3
AbbVie1
Acerta Pharma BV1
Amgen1
Antisoma Research1
Ariad Pharmaceuticals1
Celgene1
Institut de Recherches Internationales Servier1
Kura Oncology, Inc.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia13
Leukemia, Myeloid, Acute6
Leukemia, Myeloid4
Bone Marrow Diseases3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Hematologic Diseases2
Hematologic Neoplasms2
Lymphatic Diseases2
Neoplasms by Histologic Type2
Bronchiolitis Obliterans Syndrome1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.